{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:24:53Z","timestamp":1785443093630,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Predomix Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We integrated untargeted serum metabolomics using high-resolution mass spectrometry with data analysis using machine learning algorithms to accurately detect early stages of the women specific cancers of breast, endometrium, cervix, and ovary across diverse age-groups and ethnicities. A two-step approach was employed wherein cancer-positive samples were first identified as a group. A second multi-class algorithm then helped to distinguish between the individual cancers of the group. The approach yielded high detection sensitivity and specificity, highlighting its utility for the development of multi-cancer detection tests especially for early-stage cancers.<\/jats:p>","DOI":"10.1038\/s41598-022-06274-9","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T11:05:58Z","timestamp":1644491158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A non-invasive method for concurrent detection of early-stage women-specific cancers"],"prefix":"10.1038","volume":"12","author":[{"given":"Ankur","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganga","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaved","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanury V. S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmuddin","family":"Saquib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"6274_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","volume":"395","author":"GR Dagenais","year":"2019","unstructured":"Dagenais, G. R. et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): A prospective cohort study. Lancet 395, 785\u2013794. https:\/\/doi.org\/10.1016\/S0140-6736(19)32007-0 (2019).","journal-title":"Lancet"},{"key":"6274_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","volume":"4","author":"C Fitzmaurice","year":"2018","unstructured":"Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the Global Burden of Disease study. JAMA Oncol. 4, 1553\u20131568 (2018).","journal-title":"JAMA Oncol."},{"key":"6274_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"6274_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M. & Jemal, A. Global cancer in women: Burden and trends. Cancer Epidemiol. Biomark. Prev. 26, 444\u2013457 (2017).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"6274_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"6274_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7314\/APJCP.2016.17.S3.43","volume":"17","author":"M Ghonchen","year":"2016","unstructured":"Ghonchen, M., Pournamdar, Z. & Salehiniya, H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac. J. Cancer Prev. 17, 43\u201346 (2016).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"6274_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30482-6","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6 (2020).","journal-title":"Lancet Glob Health."},{"key":"6274_CR8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3389\/fonc.2019.01440","volume":"9","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Global regional and national burden of endometrial cancer, 1990\u20132017: Results from the global burden of disease study, 2017. Front Oncol 9, 1440. https:\/\/doi.org\/10.3389\/fonc.2019.01440 (2019).","journal-title":"Front Oncol"},{"key":"6274_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed, Z., Tiznobaik, A., Taheri, S. & Salehiniya, H. Ovarian cancer in the world: Epidemiology and risk factors. Int. J. Womens Health 11, 287\u2013299 (2019).","journal-title":"Int. J. Womens Health"},{"key":"6274_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 20200. CA Cancer J. Clin. 70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"6274_CR11","volume-title":"SEER Cancer Statistics Review, 1975\u20132014","year":"2017","unstructured":"Howlader, N. et al. (eds) SEER Cancer Statistics Review, 1975\u20132014 (National Cancer Institute, 2017)."},{"key":"6274_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-018-0066-x","author":"DA Ahlquist","year":"2018","unstructured":"Ahlquist, D. A. Universal cancer screening: Revolutionary, rational, and realizable. NPJ Precis Oncol. https:\/\/doi.org\/10.1038\/s41698-018-0066-x (2018).","journal-title":"NPJ Precis Oncol."},{"key":"6274_CR13","unstructured":"World Health Organization. Guide to early cancer diagnosis. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/254500\/9789241511940-eng.pdf?sequence=1&isAllowed=y (2017)."},{"key":"6274_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.11101887","volume":"259","author":"PJ Pickhardt","year":"2011","unstructured":"Pickhardt, P. J., Hassan, C., Halligan, S. & Marmo, R. Colorectal cancer: CT colonography and colonoscopy for detection\u2014Systematic review and metaanalysis. Radiology 259, 393\u2013405 (2011).","journal-title":"Radiology"},{"key":"6274_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<3::AID-SSU2>3.0.CO;2-I","volume":"18","author":"MK Brawer","year":"2000","unstructured":"Brawer, M. K. Prostate-specific antigen. Semin. Surg. Oncol. 18, 3\u20139 (2000).","journal-title":"Semin. Surg. Oncol."},{"key":"6274_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.breast.2007.07.035","volume":"17","author":"FJHM van den Biggelaar","year":"2008","unstructured":"van den Biggelaar, F. J. H. M., Nelemans, P. J. & Flobbe, K. Performance of radiographers in mammogram interpretation: A systematic review. Breast 17, 85\u201390 (2008).","journal-title":"Breast"},{"key":"6274_CR17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.6004\/jnccn.2010.0103","volume":"8","author":"EE Partridge","year":"2010","unstructured":"Partridge, E. E. et al. Cervical cancer screening. J. Natl. Compr. Canc. Netw. 8, 1358\u20131386 (2010).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"6274_CR18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMsb1616281","volume":"376","author":"PF Pinsky","year":"2017","unstructured":"Pinsky, P. F., Prorok, P. C. & Kramer, B. S. Prostate cancer screening\u2014A perspective on the current state of the evidence. N. Engl. J. Med. 376, 1285\u20131289 (2017).","journal-title":"N. Engl. J. Med."},{"key":"6274_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ypmed.2003.12.011","volume":"38","author":"S Subramanian","year":"2004","unstructured":"Subramanian, S., Klosterman, M., Amonkar, M. M. & Hunt, T. L. Adherence with colorectal cancer screening guidelines: A review. Prev. Med. 38, 536\u2013550 (2004).","journal-title":"Prev. Med."},{"key":"6274_CR20","first-page":"256","volume":"4","author":"N Goossens","year":"2015","unstructured":"Goossens, N., Nakagawa, S., Sun, X. & Hoshida, Y. Cancer biomarker discovery and validation. Transl. Cancer Res. 4, 256\u2013269 (2015).","journal-title":"Transl. Cancer Res."},{"key":"6274_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9601","author":"AM Lennon","year":"2020","unstructured":"Lennon, A. M. et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science https:\/\/doi.org\/10.1126\/science.abb9601 (2020).","journal-title":"Science"},{"key":"6274_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C. & Seiden, M. V. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745\u2013759 (2020).","journal-title":"Ann. Oncol."},{"key":"6274_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17316-z","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-020-17316-z (2020).","journal-title":"Nat. Commun."},{"key":"6274_CR24","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1158\/1055-9965.EPI-20-0074","volume":"29","author":"AH Ren","year":"2020","unstructured":"Ren, A. H., Fiala, C. A., Diamandis, E. P. & Kulasingam, V. Pitfalls in cancer biomarker discovery and validation with emphasis on circulating tumor DNA. Cancer Epidemiol. Biomark. Prev. 29, 2568\u20132574 (2020).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"6274_CR25","doi-asserted-by":"publisher","DOI":"10.21767\/2472-1646.100050","author":"L Wang","year":"2018","unstructured":"Wang, L., Liu, X. & Yang, Q. Application of metabolomics in cancer research: As a powerful tool to screen biomarker for diagnosis, monitoring and prognosis of cancer. Biomark. J. https:\/\/doi.org\/10.21767\/2472-1646.100050 (2018).","journal-title":"Biomark. J."},{"key":"6274_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin, J. L., Serkova, N. J. & Eckhardt, S. G. Clinical applications of metabolomics in oncology: A review. Clin. Cancer Res. 15, 431\u2013440 (2009).","journal-title":"Clin. Cancer Res."},{"key":"6274_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/17425255.2016.1238460","volume":"12","author":"VJ Hwang","year":"2016","unstructured":"Hwang, V. J. & Weiss, R. H. Metabolomic profiling for early cancer detection: Current status and future prospects. Expert Opin. Drug Metab. Toxicol. 12, 1263\u20131265 (2016).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"6274_CR28","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.2147\/OTT.S215628","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Li, Z., Li, H. & Jiang, Y. Metabolomics: A promising diagnostic and therapeutic implement for breast cancer. Onco Targets Ther. 12, 6797\u20136811 (2019).","journal-title":"Onco Targets Ther."},{"key":"6274_CR29","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1002\/ijc.31996","volume":"144","author":"B Yuan","year":"2019","unstructured":"Yuan, B. et al. A plasma metabolite panel as biomarkers for early primary breast cancer detection. Int. J. Cancer 144, 2833\u20132842 (2019).","journal-title":"Int. J. Cancer"},{"key":"6274_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/354671","author":"A Zhang","year":"2015","unstructured":"Zhang, A., Sun, H., Yan, G., Wang, P. & Wang, X. Metabolomics for biomarker discovery: Moving to the clinic. Biomed. Res. Int. https:\/\/doi.org\/10.1155\/2015\/354671 (2015).","journal-title":"Biomed. Res. Int."},{"key":"6274_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2015.00023","author":"A Alonso","year":"2015","unstructured":"Alonso, A., Marsal, S. & Julia, A. Analytical methods in untargeted metabolomics: State of the art in 2015. Front Bioeng Biotechnol. https:\/\/doi.org\/10.3389\/fbioe.2015.00023 (2015).","journal-title":"Front Bioeng Biotechnol."},{"key":"6274_CR32","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","volume":"27","author":"AC Schrimpe-Rutledge","year":"2016","unstructured":"Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D. & McLean, J. A. Untargeted metabolomics strategies\u2014Challenges and emerging directions. J. Am. Soc. Mass Spectrom. 27, 1897\u20131905 (2016).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"6274_CR33","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1021\/cr068287r","volume":"107","author":"HJ Issaq","year":"2007","unstructured":"Issaq, H. J., Xiao, Z. & Veenstra, T. D. Serum and plasma proteomics. Chem. Rev. 107, 3601\u20133620 (2007).","journal-title":"Chem. Rev."},{"key":"6274_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1021\/ac051312t","volume":"78","author":"EJ Want","year":"2006","unstructured":"Want, E. J. et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78, 743\u2013752 (2006).","journal-title":"Anal. Chem."},{"issue":"1","key":"6274_CR35","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1038\/s41598-019-44923-8","volume":"9","author":"F Brochu","year":"2019","unstructured":"Brochu, F. et al. Mass spectra alignment using virtual lock-masses. Sci. Rep. 9(1), 8469. https:\/\/doi.org\/10.1038\/s41598-019-44923-8 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"6274_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11306-011-0350-z","volume":"8","author":"SM Kohl","year":"2012","unstructured":"Kohl, S. M. et al. State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics 8(1), 146\u2013160. https:\/\/doi.org\/10.1007\/s11306-011-0350-z (2012).","journal-title":"Metabolomics"},{"key":"6274_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/metabo4020433","volume":"4","author":"PS Gromski","year":"2014","unstructured":"Gromski, P. S. et al. Metabolites 4, 433\u2013452 (2014).","journal-title":"Metabolites"},{"key":"6274_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs, L. K. & DeBerardinis, R. J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351\u2013359 (2015).","journal-title":"Nat. Cell Biol."},{"key":"6274_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M. & Jemal, A. Global cancer burden in women: Burden and trends. Cancer Epidemiol. Biomark. Prev. 26, 444\u2013457 (2017).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"6274_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"6274_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/data2030030","author":"Z Kakushadze","year":"2017","unstructured":"Kakushadze, Z., Raghubanshi, R. & Yu, W. Estimating cost savings from early cancer diagnosis. Data https:\/\/doi.org\/10.3390\/data2030030 (2017).","journal-title":"Data"},{"key":"6274_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"6274_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9601","author":"AM Lennon","year":"2020","unstructured":"Lennon, A. M. et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science https:\/\/doi.org\/10.1126\/science.abb9601 (2020).","journal-title":"Science"},{"key":"6274_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu, M. C. et al.. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745\u2013759 (2020).","journal-title":"Ann. Oncol."},{"key":"6274_CR45","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein, E. A. et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann. Oncol. 32, 1167\u20131177 (2021).","journal-title":"Ann. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06274-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06274-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06274-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:40:37Z","timestamp":1669329637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06274-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6274"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06274-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"11 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.G, G.S., Z.S. and N.S. are fulltime employees of PredOmix Technologies Private Limited. K.V.S.R., R.A. and S.N. are cofounders and own stock in both PredOmix Technologies Private Limited and PredOmix, Inc. The work described in this report is the subject of an International PCT filing. Application No. PCT\/US21\/48337.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2301"}}